X4 Pharmaceuticals Inc (NASDAQ:XFOR)
| 0.9833 BATS BZX Real-Time Price As of Oct 02 |  0.00 / 0.00%Today’s Change | 0.65 Today|||52-Week Range 2.58 | -0.98% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -13.2M | -23.0M | -33.9M | -43.0M | |
| Depreciation | 389.0K | 285.0K | 195.0K | 155.0K | ||
| Total Other Cash Flow | 566.0K | 1.6M | 2.4M | 6.4M | ||
| Funds From Operations | -12.3M | -21.1M | -31.3M | -36.4M | ||
| Funds From/For Other Operating Expenses | -1.4M | 517.0K | -3.4M | 4.5M | ||
| Net Cash Flow - Operating Activities | -10.8M | -21.6M | -27.9M | -40.9M | ||
| Investing | Increase In Investments | -77.0K | -65.0K | 0.00 | 0.00 | |
| Decrease In Investments | 0.00 | 0.00 | 76.0K | 0.00 | ||
| Capital Expenditures | -170.0K | -73.0K | -42.0K | -34.0K | ||
| Net Cash Flow Investing | -247.0K | -138.0K | 34.0K | -34.0K | ||
| Financing | Short Term Borrowings | 4.0M | 5.5M | 4.9M | 0.00 | |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 7.0M | 5.5M | 106.1M | 179.0K | ||
| Common Preferred Redeemed | -12.0K | -87.0K | -197.0K | 0.00 | ||
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 7.9M | 43.0K | ||
| Net Cash Flow - Financing | 11.5M | 18.1M | 101.3M | -4.5M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -122.0K | -94.0K | 333.0K | -286.0K | |
| Net Change In Cash | 442.0K | -3.6M | 73.4M | -45.5M | ||
